#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperchylomicronaemia Ventricular tachycardia Severe myoclonic epilepsy of infancy Hypomagnesaemia Glycogen storage disease type II Ovarian cancer stage IV Squamous cell carcinoma of head and neck Polymyositis Adenoid cystic carcinoma Systemic scleroderma Cutaneous T-cell lymphoma refractory Leiomyosarcoma metastatic Burkitt's lymphoma Metabolic disorder Mantle cell lymphoma More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Treatment Angelman’s syndrome – Treatment Inclusion body myositis – Diagnostics Hereditary optic atrophy – Life with Disease Methylmalonic acidaemia – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) Short-bowel syndrome – Basic Information Splenic marginal zone lymphoma – Life with Disease Richter’s syndrome – Basic Information Tuberous sclerosis complex – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dapansutrile Bms-986442 Montelukast Sodium Naloxegol Oxalate Lactulose Amcenestrant Poloxamer 407 ADX-324 Obefazimod Meropenem Anhydrous Fexofenadine Deupirfenidone Indacaterol Maleate Flortaucipir (18F) 10-1074-Ls Nacystelyn Glutenin Betaxolol Meldonium BENZYDAMINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Herpes simplex Venous thrombosis limb Chronic hepatic failure Burkitt's lymphoma Cutaneous lupus erythematosus Dry eye Eye disorder Chordoma Neuroblastoma recurrent Glanzmann's disease Short stature Neoplasm malignant Pulmonary alveolar haemorrhage Cardiogenic shock Acute myocardial infarction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • B-cell lymphoma
    Investigated Drugs:
    • Pembrolizumab
    France Germany Italy The Netherlands Portugal Sweden

  • Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Mesna
    • Filgrastim
    • Ifosfamide
    Austria Belgium Finland Germany Greece Hungary +2

  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Fondaparinux Sodium
    • Heparin Calcium
    France

  • Study on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Radium Ra 223 Dichloride
    • Cabazitaxel
    Belgium

  • Study on Recombinant Human Interferon Gamma 1b and Sodium Chloride for Treating Ventilator-Associated Pneumonia in ICU Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Recombinant Human Interferon Gamma 1B
    • Sodium Chloride
    France

  • Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Dexchlorpheniramine
    • Methylprednisolone Hemisuccinate
    • Pioglitazone
    France
Previous Page
1 … 581 582 583 584 585 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!